Dupilumab Add‐On Therapy in Severe Refractory Darier Disease
International Journal of Dermatology · 14.07.2026
DOI: 10.1111/ijd.70583 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 14.07.2026. Verfasst von Nedim Uysal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Gülhane Training and Research Hospital, Ankara, Türkiye. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, Gülhane Training and Research Hospital, Ankara, Türkiye.
ORCID-Profile: Nedim Uysal, Anıl Çağrı Tuna, Ayşenur Botsalı
Zitieren
APA
Uysal, N., Tuna, A. Ç., & Botsalı, A. (2026). Dupilumab Add‐On Therapy in Severe Refractory Darier Disease. International Journal of Dermatology. https://doi.org/10.1111/ijd.70583
Vancouver
Uysal N, Tuna AÇ, Botsalı A. Dupilumab Add‐On Therapy in Severe Refractory Darier Disease. International Journal of Dermatology. 2026. doi:10.1111/ijd.70583
BibTeX
@article{Uysal2026,
author = {Uysal, Nedim and Tuna, Anıl Çağrı and Botsalı, Ayşenur},
title = {Dupilumab Add‐On Therapy in Severe Refractory Darier Disease},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70583}
}
EUVIMED